Related Experiment Video
Updated: Mar 27, 2026

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
Published on: January 19, 2019
Research Battles: Survival Tips From a Veteran
1graduated with a undergraduate degree in biochemistry, with high distinction, from the University of Kentucky. She went on to receive her medical degree from Vanderbilt University School of Medicine in 1985. She completed a residency in internal medicine at the Department of Veteran's Affairs Medical Center at New York University Medical School, and she is board certified in internal medicine. Since 1985, Dr Isaacs had researched with Nicholas Gonzalez, md , until his untimely passing this year. She currently practices internal medicine in New York, New York.
Flaws in clinical trial designs, often used for pharmaceutical products, can derail studies of non-orthodox medical treatments. These issues include randomization problems, missing lead-in periods, and inadequate screening, leading to unintended consequences in research.
Area of Science:
- Integrative medicine
- Clinical trial methodology
- Medical research ethics
Background:
- Conventional clinical trial designs may be ill-suited for evaluating non-orthodox medical treatments.
- Existing research methodologies may not adequately address the unique challenges posed by alternative therapies.
- Ensuring the integrity and validity of studies on non-traditional medical interventions is crucial.
Purpose of the Study:
- To identify inherent design flaws in clinical trials that negatively impact studies of non-orthodox medical treatments.
- To explore the unintended consequences arising from specific methodological shortcomings in such trials.
- To highlight the importance of appropriate trial design for alternative medicine research.
Main Methods:
- Analysis of common clinical trial design elements and their suitability for non-orthodox treatments.
- Identification of potential pitfalls such as inadequate randomization, absence of lead-in periods, and insufficient screening.
- Case study or experiential account of a mismanaged trial involving non-traditional therapies.
Main Results:
- Inappropriate application of pharmaceutical trial designs can lead to flawed results in non-orthodox treatment studies.
- Key issues identified include problems with randomization, lack of lead-in periods, and insufficient participant screening.
- Inadequate trial publicity can further compromise the research process and outcomes.
Conclusions:
- Clinical trial designs require adaptation when evaluating non-orthodox medical treatments to avoid inherent flaws.
- Methodological adjustments are necessary to mitigate unintended consequences and ensure reliable research findings.
- Attention to trial design specifics, including publicity and screening, is vital for the successful study of alternative medicine.
Related Concept Videos
Life Histories
Survival Tree
Building a Survival Tree
Constructing a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Assumptions of Survival Analysis
Optimal Foraging

